Vasoactive

Vasoactive
Specialty	Cardiology, Pharmacology

Vasoactive refers to substances or agents that affect the tone and diameter of blood vessels. These agents can either constrict or dilate blood vessels, thereby influencing blood pressure and blood flow. Vasoactive substances play a crucial role in the regulation of the cardiovascular system and are often used in clinical settings to manage various medical conditions.

Types of Vasoactive Agents

Vasoactive agents can be broadly classified into two categories based on their effects on blood vessels:

Vasoconstrictors

Vasoconstrictors are agents that cause the narrowing of blood vessels, leading to an increase in blood pressure. Common vasoconstrictors include:

• Norepinephrine
• Epinephrine
• Vasopressin
• Angiotensin II

These agents are often used in the treatment of hypotension and shock to maintain adequate perfusion to vital organs.

Vasodilators

Vasodilators are agents that cause the widening of blood vessels, resulting in a decrease in blood pressure. Common vasodilators include:

• Nitroglycerin
• Sodium nitroprusside
• Hydralazine
• Calcium channel blockers

Vasodilators are used in the management of conditions such as hypertension, heart failure, and angina pectoris.

Mechanisms of Action

Vasoactive agents exert their effects through various mechanisms, including:

• Receptor-mediated pathways: Many vasoactive agents act by binding to specific receptors on the surface of vascular smooth muscle cells, such as alpha-adrenergic receptors for vasoconstrictors and beta-adrenergic receptors for vasodilators.
• Ion channel modulation: Some agents affect the flow of ions such as calcium and potassium across cell membranes, altering the contractility of vascular smooth muscle.
• Nitric oxide pathway: Vasodilators like nitroglycerin release nitric oxide, which activates guanylate cyclase in smooth muscle cells, leading to relaxation and vasodilation.

Clinical Applications

Vasoactive agents are used in various clinical scenarios, including:

• Management of shock: In conditions like septic shock, vasoactive agents are used to support blood pressure and improve tissue perfusion.
• Treatment of heart failure: Vasodilators can reduce the workload on the heart by decreasing systemic vascular resistance.
• Control of hypertension: Vasodilators are a key component in the pharmacological management of high blood pressure.

Side Effects and Considerations

The use of vasoactive agents can be associated with side effects such as:

• Hypotension: Excessive vasodilation can lead to dangerously low blood pressure.
• Tachycardia: Some vasodilators can cause reflex tachycardia as a compensatory mechanism.
• Arrhythmias: Certain agents may predispose patients to cardiac arrhythmias.

Careful monitoring and titration of vasoactive agents are essential to minimize adverse effects and achieve therapeutic goals.

Also see

• Cardiovascular system
• Pharmacology
• Blood pressure
• Shock (circulatory)
• Hypertension

Cardiovascular disease A-Z

Most common cardiac diseases

• Cardiac arrhythmia‎
• Cardiogenetic disorders‎
• Cardiomegaly‎
• Cardiomyopathy‎
• Cardiopulmonary resuscitation‎
• Chronic rheumatic heart diseases‎
• Congenital heart defects‎
• Heart neoplasia‎
• Ischemic heart diseases‎
• Pericardial disorders
• Syndromes affecting the heart‎
• Valvular heart disease‎

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

A

• Accelerated idioventricular rhythm
• Acute decompensated heart failure
• Arteriosclerotic heart disease
• Athletic heart syndrome
• Atrial flutter
• Atrioventricular fistula
• Cardiovascular disease in Australia
• Autoimmune heart disease

B

• Brown atrophy of the heart

C

• Ebb Cade
• Cardiac allograft vasculopathy
• Cardiac amyloidosis
• Cardiac asthma
• Cardiac tamponade
• Cardiogenic shock
• Cardiogeriatrics
• Cardiorenal syndrome
• Cardiotoxicity
• Carditis
• Coronary artery aneurysm
• Coronary artery anomaly
• Coronary artery disease
• Spontaneous coronary artery dissection
• Coronary artery ectasia
• Coronary occlusion
• Coronary steal
• Coronary thrombosis
• Coronary vasospasm
• Cœur en sabot
• Coxsackievirus-induced cardiomyopathy

D

• Duke Treadmill Score
• Duroziez's disease

E

• Eisenmenger's syndrome
• Embryocardia
• Endocardial fibroelastosis
• Eosinophilic myocarditis

H

• Heart attack
• Heart failure
• Heart failure with preserved ejection fraction
• Heart to Heart (1949 film)
• High-output heart failure
• Hyperdynamic precordium

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

I

• Idiopathic giant-cell myocarditis
• Interventricular dyssynchrony
• Intraventricular dyssynchrony
• Isolated atrial amyloidosis

K

• Keshan disease

L

• Loeffler endocarditis

M

• Mydicar
• Myocardial bridge
• Myocardial disarray
• Myocardial rupture
• Myocardial scarring
• Myocardial stunning
• Myocarditis

N

• Nonbacterial thrombotic endocarditis

O

• OLR1
• Ostial disease

P

• Papillary fibroelastoma
• Pathophysiology of heart failure
• Postpericardiotomy syndrome
• Pulmonary vein stenosis

R

• Right axis deviation
• Roemheld syndrome

S

• Saturated fat and cardiovascular disease
• SCAR-Fc
• Shone's syndrome
• Strain pattern
• Subacute bacterial endocarditis
• Sudden cardiac death of athletes

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

T

• Traumatic cardiac arrest

V

• Ventricular aneurysm
• Vibroacoustic disease
• Viral cardiomyopathy

W

• Waon therapy